Turku, Finland

Leena Laurén

This inventor holds 1 USPTO granted patent. Top assignee: Leiras Oy. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leena Laurén. Retrieved from https://idiyas.com/inventor/leena-laurandeacuten

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leena Laurén: Innovator in Pharmaceutical Chemistry

Introduction

Leena Laurén is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on methylenebisphosphonic acid derivatives. Her research has the potential to impact various medical applications.

Latest Patents

Leena Laurén holds a patent for novel halogen substituted methylenebisphosphonic acid anhydrides, ester anhydrides, amide anhydrides, and ester amide anhydrides. The patent outlines processes for the preparation of these novel compounds, as well as pharmaceutical preparations that incorporate them. This innovation represents a significant advancement in the development of pharmaceutical compounds.

Career Highlights

Leena Laurén is associated with Leiras Oy, a company known for its focus on pharmaceutical research and development. Her work at Leiras Oy has allowed her to explore and develop new chemical compounds that can lead to improved therapeutic options.

Collaborations

Leena has collaborated with notable colleagues such as Esko Pohjala and Heikki Nupponen. These collaborations have contributed to her success in the field and have fostered a productive research environment.

Conclusion

Leena Laurén's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…